Love Hemp, Reviewed
One of the UK's longest-standing CBD names, with the paperwork broadly where it should be. The catalogue sprawls, though — and the milligrams are rarely the cheapest way to buy them.
By Gemma Hartley
Every regulated market ends up with a few names that simply persist. In UK CBD, Love Hemp is one of them: a London brand that has been selling through the entire novel-foods saga — the deadlines, the list revisions, the slow grind towards the first authorisations — and is still standing in more or less every format the category sells. Longevity is not a virtue by itself. But in a market where the regulatory process has quietly filtered out a great many companies, still-here is information, and it is where this review starts.
The facts, up front
The regulatory position, read carefully
Love Hemp has long positioned itself as one of the compliant operators — the company has said its products are covered by novel-food applications, and it was among the names engaging with the FSA process early rather than late. That positioning is credible, but our advice does not change for credible brands: the FSA’s public list works at product level, so check the specific oil or gummy you intend to buy, not the brand name. It is a one-minute habit — our explainer on the 1mg rule and the public list walks through it — and it is the single check that outranks everything else on this page.
The lab-report side holds up its end. Reports are published, batch matching is possible, and the potency panel is where you confirm that the milligrams on the label are the milligrams in the bottle. A brand that makes that check easy has understood what the paperwork is for, and Love Hemp broadly does.
What you’re buying
The catalogue is the brand’s proudest feature and, we will argue below, its biggest problem. Oils across several strengths and flavours, sprays, capsules, gummies, topicals, drinks — if the category sells it, Love Hemp probably lists it. The products are marketed for everyday routines, and users report choosing the brand for exactly the reasons you would guess: it is familiar, it is available, and the format they want exists.
Availability deserves its own sentence, because it is rarer than it sounds. Love Hemp has cultivated a retail presence beyond its own website over the years, and a brand that must satisfy retail buyers as well as regulators tends to keep its labelling and its claims tidier than one selling only to its own mailing list. That is an incentive structure, not a guarantee — but incentives are most of what a buyer can actually inspect from the outside, and this one points the right way.
Since this is a review of food products, the standing frame belongs here in plain words: CBD sold this way is a food supplement, not a medicine — nothing in the range is intended to diagnose, treat, cure, or prevent anything, and all of it is for adults. Any brand implying otherwise would be making our con list for a different reason; to its credit, Love Hemp’s own copy generally stays on the right side of that line.
The cons, with the arithmetic shown
Price per milligram is the first problem. Work out what a milligram of CBD costs across the oils and you land mid-table at best, drifting towards premium at the higher strengths — without the single distinguishing feature (an unusual formulation, an authorisation-in-hand, a hardship programme) that usually justifies a premium. You are paying, in part, for the brand’s persistence. That is not irrational, but it should be a decision rather than an accident, and the label will not do the arithmetic for you.
The range sprawl is the second, and it compounds the first. When one brand sells the same milligrams as an oil, a spray, a capsule, a gummy, and a drink — each at a different effective price per mg, each in multiple strengths and flavours — comparison shopping inside the brand becomes genuine work. Do the per-mg arithmetic across formats and the spread is wide enough that two shoppers buying “the same” daily amount can pay meaningfully different totals depending on format alone. A tighter catalogue would serve buyers better; this one serves the shelf.
Third, sprawl has a regulatory cost too. Every SKU is another line to verify against the public list, another batch report to publish and maintain. Nothing we saw suggests neglect — but the more a catalogue multiplies, the more the buyer’s product-level check matters, and the less the brand name can carry.
Pros and cons
Verdict
The recommendation, pharmacist-style: if you want a UK brand with history, published lab reports, and a stated novel-food position, Love Hemp is a defensible default — verify your exact product on the FSA list, match the batch report, and buy the format with the honest per-mg price rather than the pleasant one. If you are optimising purely for cost per verified milligram, the sprawl means the best value in the catalogue takes effort to find, and better arithmetic may exist elsewhere. Either way, do the two checks first. They cost nothing, which is more than we can say for the gummies.